» Articles » PMID: 2565361

A Metabolite of Buspirone Increases Locus Coeruleus Activity Via Alpha 2-receptor Blockade

Overview
Journal J Neural Transm
Specialties Neurology
Physiology
Date 1989 Jan 1
PMID 2565361
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular single unit recording techniques was used to pharmacologically analyze the excitatory action of buspirone on locus coeruleus (LC) noradrenergic neurons. Intravenously administered buspirone (0.5-8 mg/kg) dose-dependently increased LC firing rate. Furthermore, pretreatment with buspirone (8 mg/kg, i.p.) caused a parallel shift to the right of the dose-response curve for the inhibitory action of the alpha 2-receptor agonist clonidine on LC neurons. The inhibitory effect of microiontophoretically applied noradrenaline on LC neurons was not altered by the simultaneous application of buspirone, but almost totally blocked by its major metabolite 1-(2-pyrimidinyl-piperazine) (1-PP). The results indicate that buspirone causes activation of LC neurons via an alpha 2-receptor antagonistic action of its metabolite, 1-PP.

Citing Articles

Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum.

Steece-Collier K, Rademacher D, Soderstrom K Basal Ganglia. 2012; 2(1):15-30.

PMID: 22712056 PMC: 3375918. DOI: 10.1016/j.baga.2012.01.002.


Increased levels of extracellular noradrenaline in the frontal cortex of rats exposed to naturalistic environmental stimuli: modulation by acute systemic administration of diazepam or buspirone.

Dalley J, Mason K, Stanford S Psychopharmacology (Berl). 1996; 127(1):47-54.

PMID: 8880943 DOI: 10.1007/BF02805974.


The yohimbine-induced anticonflict effect in the rat, Part I. Involvement of noradrenergic, serotonergic and endozepinergic(?) mechanisms.

Soderpalm A, BLOMQVIST O, Soderpalm B J Neural Transm Gen Sect. 1995; 100(3):175-89.

PMID: 8748665 DOI: 10.1007/BF01276457.


1-(2-pyrimidinyl)-piperazine may alter the effects of the 5-HT1A agonist in the learned helplessness paradigm in rats.

MARTIN P Psychopharmacology (Berl). 1991; 104(2):275-8.

PMID: 1678895 DOI: 10.1007/BF02244191.


Regulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment.

Lafaille F, Welner S J Psychiatry Neurosci. 1991; 16(4):209-14.

PMID: 1664741 PMC: 1188338.

References
1.
Schuckit M . Clinical studies of buspirone. Psychopathology. 1984; 17 Suppl 3:61-8. DOI: 10.1159/000284132. View

2.
Svensson T, Bunney B, Aghajanian G . Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res. 1975; 92(2):291-306. DOI: 10.1016/0006-8993(75)90276-0. View

3.
Seidel W, Cohen S, Bliwise N, Dement W . Buspirone: an anxiolytic without sedative effect. Psychopharmacology (Berl). 1985; 87(3):371-3. DOI: 10.1007/BF00432724. View

4.
Aston-Jones G, Bloom F . Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci. 1981; 1(8):876-86. PMC: 6564235. View

5.
Cedarbaum J, Aghajanian G . Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the alpha-antagonist piperoxane. Brain Res. 1976; 112(2):413-9. DOI: 10.1016/0006-8993(76)90297-3. View